Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — June 5, 2025

Thursday, June 5, 2025 at 8:00 a.m.
Posted: May 30, 2025 9 a.m.

Overview

This meeting will be by Webex Conference Call.

Join by the webinar number

  • Webinar number (access code):  2533 381 2052
  • Webinar password: ATTENDEE123 (28836333 when dialing from a phone or video system)

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll

If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Stacy Hart, Stacy.Hart@mass.gov or 857-274-1120 in advance of the meeting. While the Board will do its best to accommodate you, certain accommodations may require distinctive requests or the hiring of

outside contractors and may not be available if requested immediately before the meeting.

Agenda

TimeItem #Item
8:00 CALL TO ORDER
8:05IIAPPROVAL OF AGENDA
8:10III

APPROVAL OF BOARD MINUTES

  • Draft of May 1, 2024, Regular Session Minutes
8:15IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation         
  • Board Delegated Review pursuant to Licensure Policy 14-02
8:20  V

FLEX

  • NABP Annual Meeting update
  • Board Member update
8:30VI

REGULATIONS

  • 247 CMR 22.00: Monetary Penalties
8:45VII

APPLICATION

9:30VIII

WAIVERS

  1. Baystate Franklin Medical Center -Institutional Sterile ISNE21022
  2. Baystate Noble Hospital – IS21024
  3. Baystate Wing Hospital ISNE21025
  4. Boston Children’s Hospital ISNE20941
  5. Dana Farber Cancer Institute Foxborough ISNE20996
  6. Dana Farber Cancer Institute at St. Elizabeth’s Medical Center ISNE21002
  7. UMass-Hahnemann Campus ISNE21038
  8. UMass Medical Center Memorial Campus-8th floor ISNE21008
10:00IX

REQUEST TO CLOSE PROBATION MATTER DUE TO PHARMACY CLOSURE

  • Walgreens 1847, DS1359, PHA-2023-0109
10:15X

REVIEW OF COMPLIANCE

  • Option Care, DS90107, PHA-2020-0066
10:30XI

REVIEW OF COMPLIANCE

  • CVS 946, DS3442; PHA-2023-0120.
10:45XII

FILE REVIEW

1CASE-2024-2783PHA-2025-0008Kayla McCracken, PTT102325
2CASE-2025-0032PHA-2025-0010Galaxy Pharmacy, DS90255
3CASE-2025-0027PHA-2025-0009Center Pharmacy, DS2730
4CASE-2025-0217PHA-2025-0016Fagron Sterile Services, NO00033
5CASE-2025-0503PHA-2025-0028Walgreens #10638, DS3585
6CASE-2025-0501PHA-2025-0030Partners of MA, DS3419
7CASE-2025-0502PHA-2025-0031Sullivan's Healthcare, Inc., DS3335
8CASE-2025-0668PHA-2025-0039PerformSpecialty, NDS31588
9CASE-2024-3584PHA-2024-0238Winn Pharmacy, DS90341
10CASE-2024-3741PHA-2025-0001Avita Pharmacy, DS90320
11CASE-2024-3747PHA-2024-0245Walgreens #13805, DS89711
12CASE-2024-3579PHA-2024-0232FarmaKeio Outsourcing, NO00056
13CASE-2024-3575PHA-2024-0239CVS #114, DS2821
14CASE-2025-0209PHA-2025-0019CVS #114, DS2821
15CASE-2025-0306PHA-2025-0020CVS/Specialty or CarelonRx Specialty Pharmacy, DS3416
11:45XIII

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant. The

12:00  LUNCH BREAK
12:30XIVADJUDICATORY SESSION (M.G.L. c. 30A, § 18)
12:45XVM.G.L. c. 112, § 65C SESSION
3:00XVIADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback